Tag: Prescription Drugs
Increased Use of Newer Meds for Diabetic Nephropathy in the U.S.
DDP-4 inhibitors used in 54 percent of visits in last quarter of 2014; ACE inhibitors, ARBs often used
Suicide Risk Not Up With New Rx of 5α-Reductase Inhibitor for BPH
But increased risk of self-harm and depression during initial 18 months after initiation of 5α-reductase
Review: Several Classes of Drugs Treat Pain of Diabetic Neuropathy
Longer-term assessments of outcomes needed, researchers say
CANA/PHEN Aids Weight Loss in Obese Without Type 2 Diabetes
Canagliflozin plus phentermine superior to placebo for weight loss at 26 weeks in obese, overweight
C1 Inhibitor Use Reduces Attacks in Hereditary Angioedema
Subcutaneous CSL830 at doses of 40 and 60 IU reduce rate of attacks, need for rescue medication
Review: Treatment Options for Benzodiazepine Dependence
Good evidence for cognitive behavioral therapy and motivational approaches to dependence
No Hemodynamic Benefit With Levosimendan After Cardiac Sx
No decrease in 30-day mortality for patients undergoing hemodynamic support after cardiac sx
TV Ads for Testosterone Tied to Increased Testing, Tx in U.S. Men
Increases in rates of new testing, testosterone initiation, initiation without a recent test
No Link for Paternal Use of MTX, Adverse Pregnancy Outcomes
Exposure of father to methotrexate in 90 days before pregnancy doesn't up adverse pregnancy outcomes
Review: Multiple DAA Regimens Effective for HCV Genotype 1
Six DAA regimens show high SVR in HCV genotype 1 without cirrhosis, even with HIV co-infection
